Research Papers

25 of 3578 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Bruton's tyrosine kinase is a possible therapeutic target in microscopic polyangiitis.
Nakade I; Tamura Y; Hashimoto F; Ariza Y; Hotta S; Fujigaya H; Arai S; Taniguchi M; Ogawa H; Nishibata Y; Masuda S; Nakazawa D; Tomaru U; Ishizu A.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of ph…
Tesser J; Gül A; Olech E; Oelke K; Lukic T; Kwok K; Ebrahim A.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with r…
Bathon JM; Centola M; Liu X; Jin Z; Ji W; Knowlton NS; Ferraz-Amaro I; Fu Q; Giles JT; Wasko MC; Stein CM; Van Eyk JE.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The therapeutic effects of gingival mesenchymal stem cells and their exosomes in a chimeric model of rheumatoid arthrit…
Bruckner S; Capria VM; Zeno B; Leblebicioglu B; Goyal K; Vasileff WK; Awan H; Willis WL; Ganesan LP; Jarjour WN.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model.
Cao D; Zheng J; Li Z; Yu Y; Chen Z; Wang Q.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Systemic sclerosis and risk of bronchiectasis: a nationwide longitudinal cohort study.
Yang B; Kim BG; Han K; Jung JH; Kim JH; Park DW; Kim SH; Kim EG; Sohn JW; Yoon HJ; Choi H; Lee H.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Ten-year radiographic and functional outcomes in rheumatoid arthritis patients in remission compared to patients in low…
Ruyssen-Witrand A; Guernec G; Dupont J; Lapuyade D; Lioté F; Vittecoq O; Degboé Y; Constantin A.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from…
Linde L; Ørnbjerg LM; Rasmussen SH; Love TJ; Loft AG; Závada J; Vencovský J; Laas K; Nordstrom D; Sokka-Isler T; Gudbjornsson B; Gröndal G; Iannone F; Ramonda R; Hellamand P; Kristianslund EK; Kvien TK; Rodrigues AM; Santos MJ; Codreanu C; Rotar Z; Tomšič M; Castrejon I; Díaz-Gonzáles F; Di Giuseppe D; Ljung L; Nissen MJ; Ciurea A; Macfarlane GJ; Heddle M; Glintborg B; Østergaard M; Hetland ML.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
CircPTPN22 modulates T-cell activation by sponging miR-4689 to regulate S1PR1 expression in patients with systemic lupu…
Jiang Z; Li S; Jia Y; Wu Q; Chen X; Zhang M; Miao Q; Zhong Z; Zhai Z; Ni B; Xiao J; Tang J.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axia…
de Wolff L; Arends S; Brouwer E; Bootsma H; Spoorenberg A.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Comprehensive analysis of serum exosome-derived lncRNAs and mRNAs from patients with rheumatoid arthritis.
Xue L; Wang B; Li X; Zhu J; Wang W; Huang F; Wang X; Jin Y; Xiong C; Tao L; Xu K; Wang J; Guo Y; Xu J; Yang X; Wang N; Gao N; Wang Y; Li K; Li M; Geng Y.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet + B cells in syste…
Yasaka K; Yamazaki T; Sato H; Shirai T; Cho M; Ishida K; Ito K; Tanaka T; Ogasawara K; Harigae H; Ishii T; Fujii H.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patien…
Schmidt WA; Dasgupta B; Sloane J; Giannelou A; Xu Y; Unizony SH; Mackie SL; Gonzalez-Gay MA; Spiera R; Warrington KJ; Villiger PM; Nivens MC; Akinlade B; Lin Y; Buttgereit F; Stone JH.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Imaging features and clinical value of <sup>18</sup>F-FDG PET/CT for predicting airway involvement in patients with rel…
Yi JW; Huang JF; Hou P; Lin ZK; Lin JS; Lin SY; Wang M; Li SY; Wang XL.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two ind…
Rodriguez-Martinez L; García-Moreno C; Perez-Pampin E; Gómara MJ; Sarmiento-Monroy JC; Lopez-Golán Y; Gómez-Puerta JA; Mera-Varela A; Conde C; Sanmartí R; Haro I; González A.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis d…
Wright M; Smed MK; Nelson JL; Olsen J; Hetland ML; Jewell NP; Zoffmann V; Jawaheer D.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing.
Beerts C; Broeckx SY; Depuydt E; Tack L; Van Hecke L; Chiers K; Van Brantegem L; Braun G; Hellmann K; de Bouvre N; Van Bruaene N; De Ryck T; Duchateau L; Van Ryssen B; Peremans K; Saunders JH; Verhoeven G; Pauwelyn G; Spaas JH.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary bi…
Tian S; Hu Y; Zhang M; Wang K; Guo G; Li B; Shang Y; Han Y.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis.
Zhang F; Cheng T; Zhang SX.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association of knee and hip osteoarthritis with the risk of falls and fractures: a systematic review and meta-analysis.
Zhang Y; Li X; Wang Y; Ge L; Pan F; Winzenberg T; Cai G.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankyl…
Hallström M; Klingberg E; Deminger A; Rehnman JB; Geijer M; Forsblad-d'Elia H.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Automatic evaluation of atlantoaxial subluxation in rheumatoid arthritis by a deep learning model.
Okita Y; Hirano T; Wang B; Nakashima Y; Minoda S; Nagahara H; Kumanogoh A.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.
Oliveira Ramos F; Rodrigues AM; Melo AT; Aguiar F; Brites L; Azevedo S; Duarte AC; Gomes JAM; Furtado C; Mourão AF; Sequeira G; Cunha I; Figueira R; Santos MJ; Fonseca JE.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identification of potential susceptibility genes in patients with primary Sjögren's syndrome-associated pulmonary arter…
Li M; Shi Y; Zhao J; Wang Q; Li M; Zhao X.
Arthritis Res Ther (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year resu…
Baraliakos X; van der Heijde D; Sieper J; Inman RD; Kameda H; Li Y; Bu X; Shmagel A; Wung P; Song IH; Deodhar A.
Arthritis Res Ther (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared